Primecap Management Co. CA Increases Holdings in CME Group Inc. (NASDAQ:CME)

Primecap Management Co. CA increased its position in CME Group Inc. (NASDAQ:CME) by 0.1% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,803,043 shares of the financial services provider’s stock after acquiring an additional 2,013 shares during the period. Primecap Management Co. CA owned approximately 0.50% of CME Group worth $354,478,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of CME. Vanguard Group Inc. grew its holdings in CME Group by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 33,451,194 shares of the financial services provider’s stock valued at $7,044,821,000 after purchasing an additional 215,044 shares during the last quarter. Capital International Investors boosted its position in shares of CME Group by 24.1% in the 1st quarter. Capital International Investors now owns 15,809,175 shares of the financial services provider’s stock worth $3,403,557,000 after buying an additional 3,069,806 shares in the last quarter. Capital World Investors grew its stake in CME Group by 8.7% in the 4th quarter. Capital World Investors now owns 14,589,867 shares of the financial services provider’s stock valued at $3,072,654,000 after acquiring an additional 1,172,575 shares during the last quarter. Bank of New York Mellon Corp increased its holdings in CME Group by 2.9% during the 1st quarter. Bank of New York Mellon Corp now owns 6,793,988 shares of the financial services provider’s stock valued at $1,462,678,000 after acquiring an additional 189,842 shares in the last quarter. Finally, Parnassus Investments LLC raised its position in CME Group by 0.4% during the fourth quarter. Parnassus Investments LLC now owns 5,667,384 shares of the financial services provider’s stock worth $1,193,551,000 after acquiring an additional 23,583 shares during the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have recently commented on CME. Piper Sandler reissued an “overweight” rating and set a $225.00 price objective on shares of CME Group in a research note on Tuesday, August 20th. Bank of America cut CME Group from a “neutral” rating to an “underperform” rating and lowered their target price for the company from $212.00 to $177.00 in a report on Tuesday, September 3rd. Barclays boosted their price target on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Keefe, Bruyette & Woods increased their price objective on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday, July 25th. Finally, JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $209.73.

Insider Transactions at CME Group

In related news, Director Bryan T. Durkin sold 7,593 shares of CME Group stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the transaction, the director now owns 55,607 shares in the company, valued at $11,932,706.13. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.30% of the company’s stock.

CME Group Stock Up 0.7 %

Shares of NASDAQ:CME opened at $218.53 on Tuesday. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. The firm has a market cap of $78.69 billion, a price-to-earnings ratio of 24.86, a PEG ratio of 8.85 and a beta of 0.55. The stock’s 50-day moving average price is $206.16 and its two-hundred day moving average price is $207.48. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $223.80.

CME Group (NASDAQ:CME) last released its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The business had revenue of $1.53 billion for the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the company earned $2.30 earnings per share. The company’s quarterly revenue was up 12.7% on a year-over-year basis. On average, research analysts forecast that CME Group Inc. will post 9.94 EPS for the current year.

CME Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 25th. Stockholders of record on Monday, September 9th will be paid a dividend of $1.15 per share. The ex-dividend date is Monday, September 9th. This represents a $4.60 annualized dividend and a dividend yield of 2.10%. CME Group’s dividend payout ratio is presently 52.33%.

CME Group Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.